AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28634002
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (ST group)
Trial: 21624895
Drug: ICD patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICD patients without appropriate therapy
Trial: 18972875
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of 40 mg pantoprazole
Trial: 18972875
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of 40 mg pantoprazole
Trial: 15756211
Drug: 5 ppm
RxNorm normalized name: silver nitrate 55 PPM TOPICAL GEL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ppm inhaled nitric oxide (iNO)
Trial: 12504835
Drug: B vitamins
RxNorm normalized name: B-50 Hi Potency B Vitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B vitamins (folate, 10 mg; vitamin B-12, 200 microg; vitamin B-6, 20 mg/day)
Trial: 12504835
Drug: L-arginine (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (24 g/day)
Trial: 8902440
Drug: Extraamniotic administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extraamniotic administration of ethacridine lactate (82 patients)
Trial: 8902440
Drug: Intracervical prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical prostaglandin (PG) E2 gel (100 patients)
Trial: 8902440
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of concentrated oxytocin (36 patients)
Trial: 1879977
Drug: Verapamil-SR 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil-SR 240 mg twice daily
Trial: 30980680
Drug: Carbapenem administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbapenem administration before or during chemotherapy
Trial: 30980680
Drug: No carbapenem
RxNorm normalized name: Carbapenem
DrugBank: Carbapenem (DB18912)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No carbapenem administration
Trial: 28446297
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous mecobalamin (HDIME)
Trial: 28446297
Drug: Bortezomib-based chemotherapy
RxNorm normalized name: Bortezomib
DrugBank: Bortezomib (DB00188)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bortezomib-based chemotherapy (Control)
Trial: 24345428
Drug: Long-acting dihydrocodeine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting dihydrocodeine tablets (DHC-Continus)
Trial: 24345428
Drug: Short-acting dihydrocodeine
RxNorm normalized name: Short-acting sulfonamides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-acting dihydrocodeine tablets
Trial: 22943608
Drug: Radiotherapy group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy group (surgical treatment + adjuvant radiotherapy)
Trial: 19954047
Drug: Intravenous levofloxacin
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous levofloxacin 500 mg once a day
Trial: 9207281
Drug: Etidronate (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etidronate (400 mg/day during 14 days every 3 months)
Trial: 9207281
Drug: Fluoride (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride (50 mg/day, enteric-coated tablets)
Trial: 3121288
Drug: Ensure (hourly)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ensure (hourly)
Trial: 3121288
Drug: Ensure (4-hourly)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ensure (4-hourly)
Trial: 3121288
Drug: PHT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PHT with Ensure (hourly) (B)
Trial: 3121288
Drug: PHT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PHT with Ensure (4-hourly) (C)
Trial: 29582543
Drug: Non-operative caries
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-operative caries treatment programme based on the Nexø method (NOCTP)
Trial: 23724615
Drug: Topical calcipotriol
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical calcipotriol and betamethasone dipropionate (combined regimen) for 4 weeks
Trial: 23724615
Drug: Topical betamethasone
RxNorm normalized name: betamethasone Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical betamethasone valerate (monotherapy) for 4 weeks
Trial: 18027038
Drug: granisetron 3
RxNorm normalized name: granisetron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: granisetron 3 mg i.v.
Trial: 18027038
Drug: dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexamethasone 8 mg i.v.
Trial: 10792122
Drug: Oral magnesium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral magnesium sulphate (MgSO4)
Trial: 9094893
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg Fe once weekly
Trial: 9094893
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg Fe once weekly with anthelminthic treatment
Trial: 28919067
Drug: Hepcidin quantification
RxNorm normalized name: Hepcidin-25
DrugBank: Hepcidin-25 (DB19226)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepcidin quantification and treatment based on hepcidin levels
Trial: 28919067
Drug: Hepcidin treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepcidin treatment recommendations: IV iron when hepcidin <20μg/L; IV iron + erythropoietin when hepcidin 20-41μg/L
Trial: 9505800
Drug: Spray-dried soya
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spray-dried soya formula with 110 mg ascorbic acid/l
Trial: 28183318
Drug: Multi-modal early
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-modal early oral nutrition (EON)
Trial: 21813428
Drug: Narrative exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrative exposure therapy (n = 29)
Trial: 20139566
Drug: Self‐etch 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self‐etch 1 step (Adper Prompt L‐Pop, 3M ESPE‐LP)
Trial: 16912024
Drug: delapril 30
RxNorm normalized name: Delapril
DrugBank: Delapril (DB13312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: delapril 30 mg twice daily
Trial: 16912024
Drug: delapril 15
RxNorm normalized name: Delapril
DrugBank: Delapril (DB13312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: delapril 15 mg twice daily
Trial: 16912024
Drug: delapril 30
RxNorm normalized name: Delapril
DrugBank: Delapril (DB13312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: delapril 30 mg once daily
Trial: 16912024
Drug: delapril 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: delapril 7.5 mg twice daily
Trial: 7993326
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 5, 10, and 20% carbon dioxide (CO2)
Trial: 7993326
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of room air
Trial: 2701745
Drug: Buspirone (BUS,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (BUS, 10 mg)
Trial: 2701745
Drug: Diazepam (DZP,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (DZP, 10 mg)
Trial: 28847326
Drug: Scrub 1
RxNorm normalized name: E-Z Scrub 107 4 % Medicated Liquid Soap
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scrub 1 (scrubs with a complex element compound with a silver-alloy embedded in its fibers)
Trial: 23500091
Drug: Fulvestrant 250
RxNorm normalized name: fulvestrant 250 MG in 5 ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fulvestrant 250 mg IM every 4 weeks
Trial: 11550733
Drug: Hypnotic-relaxation training
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic-relaxation training
Trial: 11550733
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no hypnotic-relaxation training)
Trial: 9593133
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg of sulbactam with 2,000 mg of ampicillin by intravenous bolus injection (3 min), repeated after 2 hours.
Trial: 9593133
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg of sulbactam with 2,000 mg of ampicillin by bolus injection (3 min) followed by a continuous infusion of the same dose over 4 hours.
Trial: 8112244
Drug: Carbamazepine-CR (CBZ-CR)
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine-CR (CBZ-CR) 20 mg/kg as a single loading dose
Trial: 8112244
Drug: Phenytoin (PHT)
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenytoin (PHT) 20 mg/kg (two-thirds at 0 h and one-third at 2 h)
Trial: 27718000
Drug: bosutinib with
RxNorm normalized name: Bosutinib
DrugBank: Bosutinib (DB06616)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: bosutinib with aprepitant (125 mg × 1)
Trial: 27718000
Drug: bosutinib alone
RxNorm normalized name: Bosutinib
DrugBank: Bosutinib (DB06616)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: bosutinib alone (100 mg × 5)
Trial: 25380241
Drug: BV 1
RxNorm normalized name: Epivir HBV 100mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BV 1 treatment (1:10,000 concentration BVA plus physiotherapy)
Trial: 25380241
Drug: BV 2
RxNorm normalized name: Epivir HBV 25 MG in 5 mL Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BV 2 treatment (1:30,000 concentration BVA plus physiotherapy)
Trial: 25380241
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (normal saline injection plus physiotherapy)
Trial: 22466026
Drug: Training group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Training group (20 minutes of daily postural and movement activities for 4 weeks)
Trial: 15353542
Drug: Intensive postremission
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive postremission chemotherapy
Trial: 15353542
Drug: Less intensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Less intensive postremission chemotherapy
Trial: 15353542
Drug: Standard four-drug/4-week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard four-drug/4-week induction course
Trial: 11594640
Drug: Increased intensity
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Increased intensity of rehabilitation therapy input without change in content
Trial: 2144208
Drug: Zoladex 3.6
RxNorm normalized name: Zoladex 3.6mg Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zoladex 3.6 mg as a depot preparation combined with flutamide 250 mg tid
Trial: 30536932
Drug: Nurse-led sleep
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-led sleep programme (4 weekly 1-hr sessions)
Trial: 23601796
Drug: Isotonic balanced
RxNorm normalized name: ISOTON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic balanced solutions (crystalloid and hydroxyethyl starch; balanced group)
Trial: 23601796
Drug: Isotonic sodium
RxNorm normalized name: ISOTONIC SODIUM CHLORIDE SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic sodium chloride solutions (crystalloid and hydroxyethyl starch; saline group)
Trial: 18236999
Drug: Montelukast (oral)
DrugBank: Montelukast (DB00471)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Montelukast (oral)
Trial: 11375295
Drug: Calcium plus
RxNorm normalized name: O Calcium Plus D
DrugBank: Cupric oxide (DB11134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium plus low doses of conjugated equine estrogen
Trial: 11375295
Drug: Calcium plus
RxNorm normalized name: O Calcium Plus D
DrugBank: Cupric oxide (DB11134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium plus conventional doses of conjugated equine estrogen
Trial: 11375295
Drug: Calcium plus
RxNorm normalized name: O Calcium Plus D
DrugBank: Cupric oxide (DB11134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium plus low doses of calcitriol
Trial: 11375295
Drug: Calcium plus
RxNorm normalized name: O Calcium Plus D
DrugBank: Cupric oxide (DB11134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium plus conventional doses of calcitriol
Trial: 9366972
Drug: Peptide T
RxNorm normalized name: Peptide T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peptide T high dose (15 mg daily for four weeks)
Trial: 9366972
Drug: Peptide T
RxNorm normalized name: Peptide T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peptide T low dose (1.5 mg daily for four weeks)
Trial: 9366972
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of high dose versus low dose Peptide T
Trial: 1760535
Drug: Felodipine 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 1.25 mg
Trial: 20615108
Drug: SMS-based insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SMS-based insulin dose titration system
Trial: 20615108
Drug: Conventional titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional titration scheme
Trial: 10573242
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with salmeterol (50 microg b.i.d.) and beclomethasone (400 microg b.i.d.)
Trial: 10573242
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with beclomethasone (400 microg b.i.d.)
Trial: 10573242
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with salmeterol (50 microg b.i.d.)
Trial: 27050252
Drug: Vitamin D-K-Calcium
RxNorm normalized name: calcium carbonate / cholecalciferol / vitamin K Chewable Tablet [Viactiv Calcium Plus D]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D-K-Calcium co-supplementation (200 IU vitamin D, 90 μg vitamin K, 500 mg calcium)
Trial: 17877601
Drug: No drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drugs (Group C)
Trial: 15085026
Drug: Nizatidine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nizatidine (2 or 4 mg/kg i.v. for infants; 2.5 or 5 mg/kg oral for children; 150 mg capsule for adolescents and adults)
Trial: 15085026
Drug: Nizatidine administration
RxNorm normalized name: Nizatidine
DrugBank: Nizatidine (DB00585)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nizatidine administration
Trial: 10374157
Drug: Heparin-surface-modified (HSM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-surface-modified (HSM) intraocular lenses (IOLs)
Trial: 3329126
Drug: Sucrose-enriched diet
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose-enriched diet (about 20 g sucrose per day)
Trial: 31912903
Drug: Oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hygiene regimen (OHR) for 2 weeks
Trial: 28787506
Drug: Azithromycin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (250 mg, 3 times a week for 2 years)
Trial: 26245599
Drug: Multiforce® (MF)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiforce® (MF) Alkaline Powder, 7.5 g twice daily
Trial: 23117443
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (telephone monitoring and treatment as usual)
Trial: 18428211
Drug: Lamotrigine (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (target dose of 300 mg/day)
Trial: 8247917
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with DTZ SR-HCTZ 120 mg-12.5 mg
Trial: 8247917
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with DTZ SR 120 mg
Trial: 8247917
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with HCTZ 12.5 mg
Trial: 31299247
Drug: Oropharyngeal spray
RxNorm normalized name: MENTHOL 1.8 mg in 10 mL OROPHARYNGEAL SPRAY [Heshoutang PuraFlex OmniRelief]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oropharyngeal spray (10 actuations of 10% lignocaine, group B)
Trial: 17468862
Drug: Curcumin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (300 mg day(-1) for 6 days)
Trial: 17468862
Drug: Talinolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Talinolol (50 mg single oral dose)
Trial: 8489440
Drug: Prophylactic surfactant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic surfactant therapy
Trial: 3829723
Drug: Aqueous anthralin
RxNorm normalized name: Anthralin
DrugBank: Anthralin (DB11157)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous anthralin cream (Drithocreme) applied overnight
Trial: 3829723
Drug: Aqueous anthralin
RxNorm normalized name: Anthralin
DrugBank: Anthralin (DB11157)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous anthralin cream (Drithocreme) applied for thirty minutes
Trial: 23526939
Drug: Newly developed
RxNorm normalized name: petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Newly developed eGFR formulas (eGFR7 and eGFR8) using serum CysC detection alone or in combination with serum Cr detection
Trial: 10549683
Drug: Zolpidem, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem, 10 mg nightly for 4 weeks
Trial: 2050833
Drug: Moclobemide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (100 mg TID)
Trial: 2050833
Drug: Phenelzine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenelzine (15 mg TID)
Trial: 6219902
Drug: Erythromycin stearate
RxNorm normalized name: Erythromycin Stearate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin stearate tablets (500 mg twice a day for 2 weeks)
Trial: 6219902
Drug: Erythromycin enteric-coated
RxNorm normalized name: erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin enteric-coated base capsules (500 mg twice a day for 2 weeks)
Trial: 24578164
Drug: Resynchronization therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resynchronization therapy (CRT-D)
Trial: 19053987
Drug: pantoprazole 80
RxNorm normalized name: pantoprazole 80 MG in 100 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pantoprazole 80 mg + 8 mg/h for 72 h
Trial: 19053987
Drug: ranitidine 50
RxNorm normalized name: ranitidine 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranitidine 50 mg + 13 mg/h for 72 h
Trial: 16891136
Drug: levalbuterol 0.31
RxNorm normalized name: levalbuterol 0.31 mg/3 mL inhalation solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: levalbuterol 0.31 mg via nebulizer
Trial: 16891136
Drug: levalbuterol 0.63
RxNorm normalized name: levalbuterol 0.63 mg/3 mL inhalation solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: levalbuterol 0.63 mg via nebulizer
Trial: 16891136
Drug: racemic albuterol
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: racemic albuterol 1.25 mg via nebulizer
Trial: 16891136
Drug: racemic albuterol
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: racemic albuterol 2.5 mg via nebulizer
Trial: 16891136
Drug: (S)-albuterol presence
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (S)-albuterol presence
Trial: 15088306
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg (2.5 ml) hyaluronan (HA) in a phosphate buffered solution
Trial: 15088306
Drug: Saline vehicle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline vehicle (2.5 ml vehicle containing only the buffer)
Trial: 15088306
Drug: Intraarticular HA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular HA treatment
Trial: 9635603
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (50 mg three times a day)
Trial: 3042126
Drug: Flunarizine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine (15 mg/day)
Trial: 30744880
Drug: Omega-3 LCPUFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 LCPUFA (722 mg/day DHA)